Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Friendly Fire? Tavenner Nomination Held Up By Sen. Harkin

This article was originally published in The Pink Sheet Daily

Executive Summary

Senate HELP Committee chairman objects to use of preventive health funds for health reform “Navigators” program.

You may also be interested in...



Congress Pressing CMS To Alleviate Part B Drug Cuts Under Sequester

A bipartisan group of 124 House members tells CMS in a recent letter that the reimbursement cuts required by sequestration are being applied in a way that may force oncology providers to turn away Medicare patients or go out of business.

Alzheimer’s Research Can’t Use Prevention Funds, Harkin Tells NIH

Senator reiterates his support for Alzheimer’s research, but says the appropriations committee will not pay for it with money intended to support proven methods to prevent disease.

Preventive Medicine Themes May Resonate In Senate HELP Committee Under New Chairman Harkin

Harkin's move to succeed the late Sen. Kennedy as chairman announced Sept. 9; Dodd retains Banking committee post but will continue to lead health reform at HELP.

Topics

UsernamePublicRestriction

Register

PS142970

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel